Waters Corp Reports 7% Sales Growth in Q4 2025

By Chris Stiles • Monday, February 09 12:24 • Permanent Link

Waters Corporation (NYSE: WAT) has reported its financial results for the fourth quarter and full year 2025, showcasing significant growth and strong performance in various areas.

In the fourth quarter of 2025, sales reached $932 million, representing a 7% increase compared to the same period in 2024. The growth was even more impressive in constant currency, with a 6% increase. The company's GAAP EPS for the fourth quarter of 2025 was $3.77, while non-GAAP EPS stood at $4.53, marking a 10% growth compared to the previous year.

For the full year 2025, sales amounted to $3,165 million, reflecting a 7% increase compared to 2024. Similar to the fourth quarter, the constant currency growth matched the reported growth at 7%. The company's GAAP EPS for the full year 2025 was $10.76, and non-GAAP EPS reached $13.13, representing an 11% increase from the previous year.

The sales growth was particularly strong in the pharmaceutical and industrial markets, where sales increased by 8% and 6% respectively in constant currency. Geographically, sales in Asia saw significant growth, increasing by 11% in constant currency for the fourth quarter and 13% for the full year.

Looking ahead, Waters Corporation has provided financial guidance for the full year and first quarter of 2026. The company expects full-year 2026 organic constant currency revenue growth to be in the range of +5.5% to +7.0%, with non-GAAP EPS projected to be in the range of $14.30 to $14.50.

In the first quarter of 2026, the company anticipates organic constant currency revenue growth to be in the range of +7.0% to +9.0%, with non-GAAP EPS expected to be in the range of $2.25 to $2.35.

The acquisition of BD Biosciences and Diagnostic Solutions is also expected to have a transformative impact on Waters Corporation, with commercial excellence initiatives aimed at driving revenue synergies and cost efficiencies.

Following these announcements, the company's shares moved -1.83%, and are now trading at a price of $387.37. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.